Dr. Mason Lu is the founder, President and CEO of MedAbome, Inc. Dr. Mason Lu is an expert in immunology, oncology and antibody Science/Technology with over 30 years of experiences in discovery and development of therapeutic antibodies. Dr. Lu has participated R&D of several blockbuster antibody drugs and holds co-inventorships of many antibody drugs that are currently under Phase I to Phase III clinical trials from Tanox, Inc. to Genentech, Inc. (Roche) and other big pharmaceutical companies.

Dr. Mason Lu is a serial entrepreneur who has successfully founded two antibody companies in China prior to MedAbome, Inc. Formerly he was a Scientist/Research Manager II in Tanox/Genentech, Inc., an Assistant Professor in Dept. of Surgical Oncology of UT-MD Anderson Cancer Center in Houston, Texas.

Dr. Mason Lu received Ph.D. from MRC-LMB and University of Cambridge, M.D. from Shanghai Second Medical University, and M.Sc. from Shanghai Cancer Institute.